Your browser doesn't support javascript.
loading
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration.
Lauper, Kim; Nordström, Dan C; Pavelka, Karel; Hernández, Maria Victoria; Kvien, Tore K; Kristianslund, Eirik Klami; Santos, Maria Jose; Rotar, Ziga; Iannone, Florenzo; Codreanu, Catalin; Lukina, Galina; Gale, Sara L; Sarsour, Khaled; Luder, Yves; Courvoisier, Delphine Sophie; Gabay, Cem.
Afiliação
  • Lauper K; Geneva University Hospitals, Geneva, Switzerland.
  • Nordström DC; SCQM Registry, Zurich, Switzerland.
  • Pavelka K; ROB-FIN Helsinki University Hospital and Helsinki University, Helsinki, Finland.
  • Hernández MV; Charles University, Prague, Czech Republic.
  • Kvien TK; Rheumatology Department, Hospital Clinic Barcelona, Barcelona, Spain.
  • Kristianslund EK; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
  • Santos MJ; Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
  • Rotar Z; Rheumatology Department, Hospital Garcia de Orta, on behalf of Reuma.pt, Almada, Portugal.
  • Iannone F; BioRx.si, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Codreanu C; GISEA, University Hospital of Bari, Bari, Italy.
  • Lukina G; Center of Rheumatic Diseases, University of Medicine and Pharmacy, Bucharest, Romania.
  • Gale SL; ARBITER, Institute of Rheumatology, Moscow, Russian Federation.
  • Sarsour K; Genentech, South San Francisco, California, USA.
  • Luder Y; Genentech, South San Francisco, California, USA.
  • Courvoisier DS; F. Hoffmann-La Roche AG, Basel, Switzerland.
  • Gabay C; Geneva University Hospitals, Geneva, Switzerland.
Ann Rheum Dis ; 77(9): 1276-1282, 2018 09.
Article em En | MEDLINE | ID: mdl-29730637

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Fator de Necrose Tumoral alfa / Antirreumáticos / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Fator de Necrose Tumoral alfa / Antirreumáticos / Anticorpos Monoclonais Humanizados Idioma: En Ano de publicação: 2018 Tipo de documento: Article